: 2 3
Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I
Los estudios clnicos SURPASS han demostrado reducciones de HbA1c de hasta 2.3% en diabetes tipo 2, mientras que el estudio SURMOUNT-1 mostr prdidas de peso de hasta aproximadamente 21% del peso corporal inicial a las 72 semanas con la dosis de 15 mg
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes Davies MJ, et al
172 Numerous clinical trials have investigated the use of rTMS in chronic tinnitus, and although results have been mixed, there appear to be positive effects
In recent tests, tirzepatide has reduced body weight by more than 25%, beating by a wide margin Ozempic and Wegovy, and, for that matter, every weight-loss medication ever sold